Tobira Therapeutics, Inc. — key financial figures for fiscal year 2015 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2015)

-$49.6M

Total Assets (FY2015)

$65.5M

Total Equity (FY2015)

$42.8M

Cash Flows from Operating Activities (FY2015)

-$31.3M

Source: Tobira Therapeutics, Inc. 10-K filing (FY2015). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.